Article Text
Letter
Proton pump inhibitors and gastric neoplasia
Statistics from Altmetric.com
Footnotes
-
Competing interests: None.
Footnotes
-
Competing interests: In the past 5 years, EJK has received research funding from Altana Pharma, AstraZeneca and Janssen Pharmaceutics, and consulting fees from AstraZeneca.
Linked Articles
- Leading article
- Digest